Soluble endoglin and transforming growth

Cerebrovascular Diseases

Volumn 33, Issue 1, 2012, Pages 16-22

  Dietmann, Anelia ^a   Lackner, Peter ^a   Fischer, Marlene ^a   Broessner, Gregor ^a   Pfausler, Bettina ^a   Helbok, Raimund ^a   Schmutzhard, Erich ^a   Beer, Ronny ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cerebral infarction; Cerebral vasospasm; Endothelium; Soluble endoglin; Subarachnoid hemorrhage; Transforming growth factor 1

Indexed keywords

ENDOGLIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BLOOD VESSEL TONE; BRAIN INFARCTION; BRAIN VASOSPASM; BRAIN VENTRICLE PERITONEUM SHUNT; CLINICAL ARTICLE; COIL EMBOLIZATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; DOPPLER ECHOGRAPHY; ENDOVASCULAR COILING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HYDROCEPHALUS; LONG TERM SURVIVAL; MALE; OUTCOME ASSESSMENT; PATHOGENESIS; PILOT STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RANKIN SCALE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STENT; SUBARACHNOID HEMORRHAGE; VASCULAR STENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGENS, CD; AUSTRIA; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROCEPHALUS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASOSPASM, INTRACRANIAL;

EID: 84856208686     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000331925     Document Type: Article

References (19)

1. Solenski NJ, Haley EC Jr, Kassell NF, Kongable G, Germanson T, Truskowski L, et al: Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med 1995; 23: 1007-1017.
2. Kolias AG, Sen J, Belli A: Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. J Neurosci Res 2009; 87: 1-11.
3. Lopez-Novoa JM, Bernabeu C: The physiological role of endoglin in the cardiovascular system. Am J Physiol Heart Circ Physiol 2010; 299:H959-H974.
4. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12: 642-649. (Pubitemid 43865232)
5. Iwasa K, Bernanke DH, Smith RR, Yamamoto Y: Nonmuscle arterial constriction after subarachnoid hemorrhage: role of growth factors derived from platelets. Neurosurgery 1993; 32: 619-624. (Pubitemid 23099528)
6. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, et al: Endoglin is a component of the transforming growth factor-receptor system in human endothelial cells. J Biol Chem 1992; 267: 19027-19030.
7. Lebrin F, Deckers M, Bertolino P, ten Dijke P: TGF-β receptor function in the endothelium. Cardiovasc Res 2005; 65: 599-608. (Pubitemid 40138980)
8. Lackner P, Dietmann A, Beer R, Fischer M, Broessner G, Helbok R, et al: Cellular microparticles as a marker for cerebral vasospasm in spontaneous subarachnoid hemorrhage. Stroke 2010; 41: 2353-2357.
9. Sloan MA, Haley EC Jr, Kassell NF, Henry ML, Stewart SR, Beskin RR, et al: Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage. Neurology 1989; 39: 1514-1518. (Pubitemid 19286013)
10. Sloan MA, Alexandrov AV, Tegeler CH, Spencer MP, Caplan LR, Feldmann E, et al: Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2004; 62: 1468-1481. (Pubitemid 38608182)
11. Broessner G, Lackner P, Hoefer C, Beer R, Helbok R, Grabmer C, et al: Influence of red blood cell transfusion on mortality and longterm functional outcome in 292 patients with spontaneous subarachnoid hemorrhage. Crit Care Med 2009; 37: 1886-1892.
12. Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman DH, et al: A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 2005; 96: 684-692. (Pubitemid 40478336)
13. Jerkic M, Rodriguez-Barbero A, Prieto M, Toporsian M, Pericacho M, Rivas-Elena JV, et al: Reduced angiogenic responses in adult Endoglin heterozygous mice. Cardiovasc Res 2006; 69: 845-854. (Pubitemid 43227983)
14. Hanggi D, Steiger HJ: Nitric oxide in subarachnoid haemorrhage and its therapeutic implications. Acta Neurochir (Wien) 2006; 148: 605-613. (Pubitemid 43881780)
15. Freyssinet JM: Cellular microparticles: what are they bad or good for? J Thromb Haemost 2003; 1: 1655-1662.
16. Douglas MR, Daniel M, Lagord C, Akinwunmi J, Jackowski A, Cooper C, et al: High CSF transforming growth factor β levels after subarachnoid haemorrhage: association with chronic communicating hydrocephalus. J Neurol Neurosurg Psychiatry 2009; 80: 545-550.
17. Flood C, Akinwunmi J, Lagord C, Daniel M, Berry M, Jackowski A, et al: Transforming growth factor-β 1 in the cerebrospinal fluid of patients with subarachnoid hemorrhage: titers derived from exogenous and endogenous sources. J Cereb Blood Flow Metab 2001; 21: 157-162. (Pubitemid 32143977)
18. Kitazawa K, Tada T: Elevation of transforming growth factor-β 1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage. Stroke 1994; 25: 1400-1404. (Pubitemid 24198587)
19. Cruz-Gonzalez I, Pabon P, Rodriguez-Barbero A, Martin-Moreiras J, Pericacho M, Sanchez PL, et al: Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction. J Cell Mol Med 2008; 12: 955-961 (Pubitemid 351718073)